Literature DB >> 2107250

Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery.

J M Boyce1, G Potter-Bynoe, L Dziobek.   

Abstract

Of the more than 200,000 patients who undergo open heart surgery annually in the United States, 2% to 10% will develop a post-operative infection related to their surgery. The economic impact of such infections on hospitals under the prospective payment system is unclear. To study the effect of such infections on hospital costs and reimbursement patterns, we compared case patients with controls of similar age, sex, urgency of surgery and type of surgery. The postoperative stay for cases was significantly longer than for matched controls (26.8 days and 8.3 days, respectively; p = .0002). The mean hospital cost for case admissions ($25,957) was twice as high as for control admissions ($12,795) (p = .0002). Cases resulted in an average net loss to the hospital of $2,344 per patient, while controls yielded an average net gain of $3,196 per patient (p = .02). We conclude that hospitals have substantial financial incentives to minimize the incidence of postoperative wound infections associated with open heart surgery.

Entities:  

Mesh:

Year:  1990        PMID: 2107250     DOI: 10.1086/646127

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  26 in total

1.  Phase II Randomized Trial of Negative-Pressure Wound Therapy to Decrease Surgical Site Infection in Patients Undergoing Laparotomy for Gastrointestinal, Pancreatic, and Peritoneal Surface Malignancies.

Authors:  Perry Shen; Aaron U Blackham; Stacey Lewis; Clancy J Clark; Russell Howerton; Harveshp D Mogal; Rebecca M Dodson; Gregory B Russell; Edward A Levine
Journal:  J Am Coll Surg       Date:  2017-01-11       Impact factor: 6.113

2.  Current Strategies for Prevention of Surgical Site Infections.

Authors:  Ronald Lee Nichols
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

3.  [Etiology and consequences of postoperative wound infection].

Authors:  M Rogy; R Függer; E Riedl; F Schulz
Journal:  Langenbecks Arch Chir       Date:  1991

Review 4.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

Review 5.  Surgical site infections--economic consequences for the health care system.

Authors:  Karolin Graf; Ella Ott; Ralf-Peter Vonberg; Christian Kuehn; Tobias Schilling; Axel Haverich; Iris Freya Chaberny
Journal:  Langenbecks Arch Surg       Date:  2011-03-15       Impact factor: 3.445

6.  Associations of Hospital Length of Stay with Surgical Site Infections.

Authors:  Edin Mujagic; Walter R Marti; Michael Coslovsky; Savas D Soysal; Robert Mechera; Marco von Strauss; Jasmin Zeindler; Franziska Saxer; Alexandra Mueller; Christoph A Fux; Christoph Kindler; Lorenz Gurke; Walter P Weber
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

7.  [IKOP-Infection control in the operating theatreConsensus on the theme "Barrier measures during operations and invasive procedures"].

Authors:  B Salzberger; M Dettenkofer; F M Baer; O Cornely; M Herrmann; J Höher; S Lemmen
Journal:  Anaesthesist       Date:  2004-08       Impact factor: 1.041

8.  The effect of surgical site infection on older operative patients.

Authors:  Keith S Kaye; Deverick J Anderson; Richard Sloane; Luke F Chen; Yong Choi; Katherine Link; Daniel J Sexton; Kenneth E Schmader
Journal:  J Am Geriatr Soc       Date:  2009-01       Impact factor: 5.562

9.  Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit.

Authors:  I Kappstein; G Schulgen; U Beyer; K Geiger; M Schumacher; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

Review 10.  Preventing surgical site infections: a surgeon's perspective.

Authors:  R L Nichols
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.